Back to search
FDAFDA · Food and drugs·Recall number D-0473-2025

Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.

Published July 2, 2025 · Recall initiated: May 23, 2025

Summary

FDA records drug Class II recall D-0473-2025, published July 2, 2025 and initiated May 23, 2025. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Ongoing; Reported quantity: 36612 cartons; Lot: Lot#: 5420094, Exp 09/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign tablets/capsules.

What to do

Voluntary: Firm initiated · Letter

Get an email if METOCLOPRAMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METOCLOPRAMIDE
Manufacturer
Teva Pharmaceuticals USA, Inc
Distributor
USA Nationwide
UPC
0300932203013
Lot
Lot#: 5420094, Exp 09/30/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01. recalled?

Yes. FDA published recall D-0473-2025 on July 2, 2025. Reported hazard: Presence of foreign tablets/capsules.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METOCLOPRAMIDE. UPC: 0300932203013.